NEW YORK (GenomeWeb News) – SomaLogic, New England Biolabs, and Gilead Sciences are suing Enzymatics in federal court for patent infringement.

In a lawsuit filed on Wednesday in US District Court for the District of Massachusetts, the plaintiffs accuse Enzymatics of infringing US Patent Nos. 5,670,637, titled "Nucleic acid ligands" and 5,874,557, titled "Nucleic acid ligand inhibitors to DNA polymerase."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.